Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasm Metastasis 1

Interventions

tempol 1talazoparib 1selitrectinib 1adagrasib 1Lapatinib 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × Neoplasm Metastasis × selitrectinib × Clear all
NCT03206931 2021-09-16

Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Bayer

No longer available
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡